Set to enter larger trial across 5 countries, it works by permanently turning off gene that causes high bad cholesterol levels. Commonly used drugs work by inhibiting cholesterol-causing enzyme.
It is still in initial stages & could eventually be integrated with mobile phones, enabling patients to monitor blood health on the go. Clinical trials conducted with around 50 patients.
For the first time, the guidelines are aimed at clinicians, individuals and medical laboratories. The cut-off for various lipid markers was modified based on risk factors.
Novartis India, the company that has the import and marketing permission for Inclisiran, refused to divulge the price of the drug in India, but market sources say it is going to be Rs 1.2 lakh per jab.
Study — led by Dr S. Anitha, senior scientist, nutrition, at ICRISAT — is a review and analysis of 8 previously published studies. It was published in the journal 'Nutrients' this month.
From Munir’s point of view, a few bumps here and there is par for the course. He isn’t going to drive his dumper truck to its doom. He wants to use it as a weapon.
COMMENTS